DOSSIER · 13F Holders · Q4 2025
RYI

VIRACTA THERAPEUTICS INC

1 institutions still hold VIRACTA THERAPEUTICS INC as of Q4 2025. Tracked across SEC 13F-HR filings, with insider and 13D/G activity surfaced alongside.

CUSIP 92765F108·1 13F holders·last filed Dec 31, 2025
Market cap
13F value held
visible holders
Holders
1
filers reporting
Concentration
Motiv8 Investments LLC #1
top holder share
AI Holders Summary · Q4 2025

1 institutions reported RYI in Q4 2025. Top-holder concentration data is loading.

Top holders

Sorted by position value. Source: SEC EDGAR 13F-HR filings.

#HolderValueShares% port.Quarter
01
Motiv8 Investments LLC
CIK 0002024873
$0140.00%Q4 2025
Insiders at VIRACTA THERAPEUTICS INC
Greiff Andrew SMarabito Richard TSiegal Michael DStovsky Richard PScott Peter JenningsClaussen James JSilver Mark S.Kannan Molly D